Treatment with interferon-α for metastatic renal cell cancer

Y. Shirasaki, T. Tsushima, T. Kurashige, N. Kusaka, R. Arata, H. Kaku, T. Saika, Y. Nasu, H. Kumon

    Research output: Contribution to journalArticlepeer-review


    We examined 51 patients treated with interferon-α for metastatic renal cell cancer. The results comprised complete response (CR) in no patients, partial response (PR) in 6 patients, no change (NC) in 34 and progression of disease (PD) in 11. The overall response rate was 11.8%. All of the responders had lung metastasis. One-, three- and five-year survival rates were 63.7%, 21.5% and 12.5%, respectively. There were 5 long-term survivors in the NC group who showed survival times in excess of 5 years, who had undergone radical nephrectomy because of good performance status.

    Original languageEnglish
    Pages (from-to)344-346
    Number of pages3
    JournalNishinihon Journal of Urology
    Issue number5
    Publication statusPublished - Jan 1 2001


    • Interferon
    • Renal cell cancer

    ASJC Scopus subject areas

    • Urology


    Dive into the research topics of 'Treatment with interferon-α for metastatic renal cell cancer'. Together they form a unique fingerprint.

    Cite this